share_log

HC Wainwright & Co. Maintains Buy on Silence Therapeutics, Lowers Price Target to $75

Benzinga ·  Nov 17, 2023 06:20

HC Wainwright & Co. analyst Patrick Trucchio maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and lowers the price target from $80 to $75.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment